ValienteManuel CNIO/Cell Division and Cancer groupSpain

Head of the Brain Metastasis Group at CNIO. He investigates the biology of brain metastasis in order to challenge this unmet clinical need using his background in Neuroscience and Cancer Biology. Specifically, his laboratory studies novel brain metastasis mediators, characterizes the metastasis-associated microenvironment, designs better experimental models and explores novel methods to target brain metastasis, including the frequent impact on brain activity. All these aims consider the brain environment as a critical component to understand the biology of this progression of cancer. Dr. Valiente has co-founded the first National Network of Brain Metastasis (RENACER) in Spain, which is allowing his team to speed up the translation of laboratory findings to the clinic in collaboration with the 18 hospitals associated. His contributions to brain metastasis research have been recognized with the Constantes y Vitales Award, Banco Sabadell Award, ASPIRE Award, ERC CoG, EMBO YIP, CLIP Award, Beug Foundation’s Prize for Metastasis Research, Bristol-Myers Squibb-MRA Young Investigator Award among others. He is Board Member of European Association of Neuro-Oncology (EANO) and Board Member of the Metastasis Research Society (MRS).